The comprehensive analysis of prostate cancer genomes revealed that the TP53 deletion is often included in a large fragment deletion that spans over almost the whole short arm of chromosome 17 (17p) (Fig. 1b). The gene discussed is TP53; the disease is prostate carcinoma.